Molecular diagnostics company Myriad Genetics, Inc. (NASDAQ:MYGN) said it planned to buy Crescendo Bioscience for $270 million to enter the autoimmune market, and raised its full-year forecast. Venture capital and private equity firm Safeguard Scientifics, which said it has a 13 percent primary ownership position in Crescendo, said it would get about $40 million in aggregate cash proceeds from the deal. Myriad Genetics, Inc. (NASDAQ:MYGN) stock opened at $30.67 in last trading session, and closed at $31.29, trading in the range of $29.10 – $32.60. The stock showed a positive weekly performance of 13.37%.
Raymond James lowered shares of Gol Linhas Aereas Inteligentes SA (NYSE:GOL) from an outperform rating to a market perform rating in a research report released on Thursday morning, TheFlyOnTheWall.com reports. Raymond James currently has $6.00 price objective on the stock. Gol Linhas Aereas Inteligentes SA (ADR) (NYSE:GOL) shares closed at $4.16 on last trade day, by gaining 5.05%. Stock 52 week range is $2.74 – $7.65. Company’s market capitalization is $1.16 billion.
Furiex Pharmaceuticals (NASDAQ:FURX) had its target price lifted by Ladenburg Thalmann from $57.00 to $137.00 in a research note released on Tuesday morning, American Banking News reports. They currently have a buy rating on the stock. Furiex Pharmaceuticals Inc (NASDAQ:FURX) stock advanced 7.44% and finished the last session at $113.55. The EPS of the stock remained -3.25. Company’s market capitalization is $1.18 billion.
Stein Mart, Inc. (NASDAQ:SMRT) average recommendation is overweight with average Target Price of $16.00. Stein Mart, Inc. (NASDAQ:SMRT) stock opened at $11.73 in last trading session and closed at $12.29. The 52 week range of the stock is $7.44 – $16.17 and the day range was $11.53 – $12.58.
Leave a Reply